Fact CheckerSign in

NCT02302742Recruiting

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

PROspective Evaluation of GErmline Mutations, Cancer Outcome and Tissue Biomarkers: A Registry for Patients With Triple Negative Breast Cancer and Germline Mutations

Source: ClinicalTrials.gov · Last updated 18 Aug 2026

Brief summary (registry, in English)

PROGECT is a registry for patients with Triple Negative breast cancer (TNBC) or patients who have an identified germline mutations (such as a mutation on the BRCA1 or BRCA2 genes).

Status (registry)
Recruiting
Study type
Observational
Enrollment
3000 (estimated)
First submitted
11 Nov 2014
Start date
22 Mar 2011
Primary completion date
Dec 2026
Lead sponsor
University of Kansas Medical Center
NCT number
NCT02302742

What you commit to

  • Study type: Observational
  • Planned participants: 3000
  • From 22 Mar 2011 to the primary completion date, Dec 2026
  • 11 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Triple Negative Breast Cancer -Patient is not within five years of diagnosis

Other

  • Germline mutation Carriers:
  • -Patient only carries a HBOC mutation that is classified as "polymorphism" of "favor polymorphism"

Who the study is looking for

  • Triple Negative Breast Cancer
  • ER/PR \<10% and HER negative per current ASCO/CAP guidelines
  • Stages I-IV
  • Any age at diagnosis
  • Patient must be within 5 years of diagnosis
  • Eligible regardless of genetic testing status
  • Genetic testing recommended for patients meeting NCCN and Medicare guidelines
    • AND/OR
    • Germline mutation Carriers
  • Patients with deleterious or uncertain mutations in HBOC genes (BRCA, PTEN, P53, -PALB2 etc) are eligible regardless of type/site of cancer
  • Healthy patients harboring mutations also eligible
  • There is no time limit from the time of diagnosis of cancer and enrollment.
  • Eligible regardless of personal history of cancer

Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (11)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hays Medical Center Dreiling-Schmidt Cancer Institute
Coordinator of this site? Confirm its status
HaysUnited StatesRecruiting
Universtiy Health
Coordinator of this site? Confirm its status
Kansas CityUnited StatesRecruiting
Research Medical Center
Coordinator of this site? Confirm its status
Kansas CityUnited StatesRecruiting
KCCC South
Coordinator of this site? Confirm its status
Kansas CityUnited StatesRecruiting
KCCC - North
Coordinator of this site? Confirm its status
Kansas CityUnited StatesRecruiting
KCCC West
Coordinator of this site? Confirm its status
Kansas CityUnited StatesRecruiting
KCCC Lee's Summit
Coordinator of this site? Confirm its status
Lee's SummitUnited StatesRecruiting
Overland Park Regional Medical Center
Coordinator of this site? Confirm its status
Overland ParkUnited StatesRecruiting
KCCC Overland Park
Coordinator of this site? Confirm its status
Overland ParkUnited StatesRecruiting
Salina Regional Health Center - Tammy Walker Cancer Center
Coordinator of this site? Confirm its status
SalinaUnited StatesRecruiting
The University of Kansas Cancer Center
Coordinator of this site? Confirm its status
WestwoodUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.